In the latest trading session, 3,397,235 Merck & Co., Inc. (NYSE:MRK) shares changed hands as the company’s beta touched 0.41. With the company’s most recent per share price at $78.22 changing hands around $0.76 or 0.01% at last look, the market valuation stands at $197.92 Billion. MRK’s current price is a discount, trading about -12.25% off its 52-week high of $87.8. The share price had its 52-week low at $71.72, which suggests the last value was 8.31% up since then. When we look at Merck & Co., Inc.’s average trading volume, we note the 10-day average is 10.56 Million shares, with the 3-month average coming to 12.08 Million.
Analysts gave the Merck & Co., Inc. (MRK) stock a consensus recommendation rating of Overweight, calculated at a mean rating of 2. If we narrow down to specifics, the data shows that none out of 23 analysts rate the stock as a Sell, with a further 4 assigning it an Overweight rating. Of the remaining, 5 recommended MRK as a Hold, 14 felt it is a Buy and none rated the stock as Underweight. Merck & Co., Inc.’s EPS for the current quarter is expected to be $1.59.
Merck & Co., Inc. (NYSE:MRK) trade information
Instantly MRK is in green as seen in intraday trades today. With action 0.98%, the performance over the past five days has been green. The jump to weekly highs of $79.18 on Monday, May 10 added 1.05% to the stock’s daily price. The company’s shares are showing year-to-date downside of -0.04%, with the 5-day performance at 0.01% in the green. However, in the 30-day time frame, Merck & Co., Inc. (NYSE:MRK) is 0.03% up. Looking at the short shares, we see there were 21.02 Million shares sold at short interest cover period of 1.74 days.
The consensus price target for the stock as assigned by Wall Street analysts is $94.65, meaning bulls need an upside of 21% from its recent market value. According to analyst projections, MRK’s forecast low is $77 with $108 as the target high. To hit the forecast high, the stock’s price needs a +38.07% upsurge from its latest level, while the stock would need to tank -1.56% for it to hit the projected low.
Merck & Co., Inc. (MRK) estimates and forecasts
Data shows that the Merck & Co., Inc. share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value dive -3.61% over the past 6 months, a 9.6% in annual growth rate that is considerably lower than the industry average of 10.1%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for Merck & Co., Inc. will rise +16.1%, while the growth in revenue is estimated to hit 4.6% for the next quarter. Year-over-year growth is forecast to reach 8.4% up from the last financial year.
Consensus estimates given by 8 financial analysts project the company’s revenue in the current quarter to hit an average of $12.61 Billion. 7 analysts are of the opinion that Merck & Co., Inc.’s revenue for the quarter ending September 01, 2021 will be $13.64 Billion. The company’s revenue for the corresponding quarters a year ago was $10.87 Billion and $12.21 Billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 16%. The estimates for the next quarter sales put growth at 11.7%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 12.2%. The 2021 estimates are for Merck & Co., Inc. earnings to decrease by -28%, but the outlook for the next 5-year period is at 9.1% per year.
Merck & Co., Inc. is expected to release its next quarterly earnings report around July 29, 2021. The 3.42% annual yield figure for the share gives it an annual dividend of 2.6. It is important to note, however, that the 3.42% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 2.94% per year.
Merck & Co., Inc. (NYSE:MRK)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.07% of Merck & Co., Inc. shares while 75.46% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 75.52%. There are 3461 institutions holding the Merck & Co., Inc. stock share, with Vanguard Group, Inc. (The) the top institutional holder. As of Dec 30, 2020, the company held 8.23% of the shares, roughly 208.41 Million MRK shares worth $17.05 Billion.
Blackrock Inc. holds the second largest percentage of outstanding shares, with 7.66% or 193.93 Million shares worth $14.95 Billion as of Mar 30, 2021.
Among Mutual Funds, the top two as of Dec 30, 2020 were Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. With 71316381 shares estimated at $5.83 Billion under it, the former controlled 2.82% of total outstanding shares. On the other hand, Vanguard 500 Index Fund held about 2% of the shares, roughly 50.7 Million shares worth around $4.15 Billion.